204 related articles for article (PubMed ID: 11395555)
21. Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma.
van de Rijn M; Barr FG; Collins MH; Xiong QB; Fisher C
Am J Clin Pathol; 1999 Jul; 112(1):43-9. PubMed ID: 10396284
[TBL] [Abstract][Full Text] [Related]
22. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
Takenaka S; Ueda T; Naka N; Araki N; Hashimoto N; Myoui A; Ozaki T; Nakayama T; Toguchida J; Tanaka K; Iwamoto Y; Matsumine A; Uchida A; Ieguchi M; Kaya M; Wada T; Baba I; Kudawara I; Aoki Y; Yoshikawa H
Oncol Rep; 2008 Feb; 19(2):467-76. PubMed ID: 18202796
[TBL] [Abstract][Full Text] [Related]
23. Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma.
Mancuso T; Mezzelani A; Riva C; Fabbri A; Dal Bo L; Sampietro G; Perego P; Casali P; Zunino F; Sozzi G; Pierotti MA; Pilotti S
Lab Invest; 2000 Jun; 80(6):805-13. PubMed ID: 10879732
[TBL] [Abstract][Full Text] [Related]
24. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
Guillou L; Benhattar J; Bonichon F; Gallagher G; Terrier P; Stauffer E; Somerhausen Nde S; Michels JJ; Jundt G; Vince DR; Taylor S; Genevay M; Collin F; Trassard M; Coindre JM
J Clin Oncol; 2004 Oct; 22(20):4040-50. PubMed ID: 15364967
[TBL] [Abstract][Full Text] [Related]
25. SYT-SSX fusion proteins in synovial sarcomas: detection and characterization with new antibodies.
Hashimoto N; Araki N; Yoshikawa H; Myoui A; Matsumine A; Kaneko M; Sonobe H; Ochi T
Cancer Lett; 2000 Feb; 149(1-2):31-6. PubMed ID: 10737705
[TBL] [Abstract][Full Text] [Related]
26. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.
Nilsson G; Skytting B; Xie Y; Brodin B; Perfekt R; Mandahl N; Lundeberg J; Uhlén M; Larsson O
Cancer Res; 1999 Jul; 59(13):3180-4. PubMed ID: 10397263
[TBL] [Abstract][Full Text] [Related]
27. Detection of SYT-SSX mutant transcripts in formalin-fixed paraffin-embedded sarcoma tissues using one-step reverse transcriptase real-time PCR.
Norlelawati AT; Mohd Danial G; Nora H; Nadia O; Zatur Rawihah K; Nor Zamzila A; Naznin M
Malays J Pathol; 2016 Apr; 38(1):11-8. PubMed ID: 27126659
[TBL] [Abstract][Full Text] [Related]
28. Detection of SYT-SSX1/2 fusion transcripts by reverse transcriptase-polymerase chain reaction (RT-PCR) is a valuable diagnostic tool in synovial sarcoma.
Willeke F; Mechtersheimer G; Schwarzbach M; Weitz J; Zimmer D; Lehnert T; Herfarth C; von Knebel Doeberitz M; Ridder R
Eur J Cancer; 1998 Dec; 34(13):2087-93. PubMed ID: 10070316
[TBL] [Abstract][Full Text] [Related]
29. A novel type of SYT/SSX fusion: methodological and biological implications.
Törnkvist M; Brodin B; Bartolazzi A; Larsson O
Mod Pathol; 2002 Jun; 15(6):679-85. PubMed ID: 12065783
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of SYT/SSX1 and SYT/SSX2 fusion genes from synovial sarcoma].
Kekeeva TV; Riazantseva AA; Zavalishina LÉ; Andreeva IuIu; Babenko OV; Zaletaev DV; Frank GA
Mol Biol (Mosk); 2011; 45(5):840-4. PubMed ID: 22393780
[TBL] [Abstract][Full Text] [Related]
31. Are there geographical differences in the frequency of SYT-SSX1 and SYT-SSX2 chimeric transcripts in synovial sarcoma?
Koković I; Bracko M; Golouh R; Ligtenberg M; van Krieken HJ; Hudler P; Komel R
Cancer Detect Prev; 2004; 28(4):294-301. PubMed ID: 15350633
[TBL] [Abstract][Full Text] [Related]
32. Synovial sarcoma. A Scandinavian Sarcoma Group project.
Skytting B
Acta Orthop Scand Suppl; 2000 Apr; 291():1-28. PubMed ID: 10862210
[TBL] [Abstract][Full Text] [Related]
33. Detection of SYT-SSX rearrangements in synovial sarcomas by real-time one-step RT-PCR.
Nikiforova MN; Groen P; Mutema G; Nikiforov YE; Witte D
Pediatr Dev Pathol; 2005; 8(2):162-7. PubMed ID: 15747098
[TBL] [Abstract][Full Text] [Related]
34. SYT-SSX fusion genes and prognosis in synovial sarcoma.
Mezzelani A; Mariani L; Tamborini E; Agus V; Riva C; Lo Vullo S; Fabbri A; Stumbo M; Azzarelli A; Casali PG; Gronchi A; Sozzi G; Pierotti MA; Pilotti S
Br J Cancer; 2001 Nov; 85(10):1535-9. PubMed ID: 11720441
[TBL] [Abstract][Full Text] [Related]
35. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
[TBL] [Abstract][Full Text] [Related]
36. The SYT-SSX fusion protein and histological epithelial differentiation in synovial sarcoma: relationship with extracellular matrix remodeling.
Saito T
Int J Clin Exp Pathol; 2013; 6(11):2272-9. PubMed ID: 24228088
[TBL] [Abstract][Full Text] [Related]
37. Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma.
Sun Y; Sun B; Wang J; Cai W; Zhao X; Zhang S; Hao X
Cancer Sci; 2009 Jun; 100(6):1018-25. PubMed ID: 19385976
[TBL] [Abstract][Full Text] [Related]
38. Novel fluorescent ligase detection reaction and flow cytometric analysis of SYT-SSX fusions in synovial sarcoma.
Gaffney R; Chakerian A; O'Connell JX; Mathers J; Garner K; Joste N; Viswanatha DS
J Mol Diagn; 2003 May; 5(2):127-35. PubMed ID: 12707378
[TBL] [Abstract][Full Text] [Related]
39. Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases.
Makhlouf HR; Ahrens W; Agarwal B; Dow N; Marshalleck JJ; Lee EL; Dotto JE; Hui P; Sobin LH; Oliveira A; Miettinen M
Am J Surg Pathol; 2008 Feb; 32(2):275-81. PubMed ID: 18223331
[TBL] [Abstract][Full Text] [Related]
40. Fusions of the SYT and SSX genes in synovial sarcoma.
Ladanyi M
Oncogene; 2001 Sep; 20(40):5755-62. PubMed ID: 11607825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
